Results 151 to 157 of about 2,299 (157)

Shared and distinct mechanisms of UBA1 inactivation across different diseases

EMBO Journal
Nadine L Samara, Kylie Walters, Sebastian Fernandez-Pol   +2 more
exaly  

Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow‐up of vacuolization and UBA1 clonal dynamics

British Journal of Haematology
Marina Díaz-Beyá, Jordi Esteve Reyner, CARLOS Jiménez-Vicente   +2 more
exaly  

A comprehensive prognostic and immune infiltration analysis of UBA1 in pan‐cancer: A computational analysis and in vitro experiments

Journal of Cellular and Molecular Medicine
Can Chen, , Shenxian Qian
exaly  

Ubiquitin-Activating Enzyme E1 (UBA1) as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Insights into Immune Infiltration and Functional Implications

International Journal of Molecular Sciences
Changshuai Zhou, Mingtao Feng, Li Liangdong   +2 more
exaly  

Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome

Rheumatology
, Naomi Tsuchida, Masaki Itagane
exaly  

Macrophage-specific UBA1 knockout attenuates sepsis-induced liver dysfunction by regulating inflammatory responses via the BMAL1/CLOCK–REV-ERBα axis

International Immunopharmacology
Hui-Hua Li
exaly  

Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence

Acta Pharmaceutica Sinica B
Xiaojun Xu, Zhiyong Mao, Ying Jiang
exaly